Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HPE1
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016407 | acetyltransferase activity | 5 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016746 | acyltransferase activity | 3 | 6 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 6 |
GO:0008080 | N-acetyltransferase activity | 6 | 1 |
GO:0016410 | N-acyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.531 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.531 |
CLV_PCSK_PC1ET2_1 | 141 | 143 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.321 |
DOC_CKS1_1 | 132 | 137 | PF01111 | 0.251 |
DOC_CYCLIN_RxL_1 | 101 | 111 | PF00134 | 0.321 |
DOC_CYCLIN_RxL_1 | 84 | 93 | PF00134 | 0.321 |
DOC_PP2B_PxIxI_1 | 3 | 9 | PF00149 | 0.488 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.260 |
LIG_14-3-3_CanoR_1 | 51 | 61 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 80 | 85 | PF00244 | 0.321 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.535 |
LIG_deltaCOP1_diTrp_1 | 148 | 158 | PF00928 | 0.686 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.315 |
LIG_LIR_Gen_1 | 17 | 28 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.469 |
LIG_PDZ_Class_2 | 153 | 158 | PF00595 | 0.546 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.543 |
LIG_SH2_NCK_1 | 29 | 33 | PF00017 | 0.563 |
LIG_SH2_STAP1 | 143 | 147 | PF00017 | 0.551 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.595 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.321 |
LIG_TRAF2_1 | 117 | 120 | PF00917 | 0.321 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.518 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.627 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.541 |
MOD_N-GLC_1 | 152 | 157 | PF02516 | 0.476 |
MOD_NEK2_2 | 4 | 9 | PF00069 | 0.618 |
MOD_PKA_1 | 13 | 19 | PF00069 | 0.455 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.321 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.545 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.260 |
MOD_SUMO_for_1 | 117 | 120 | PF00179 | 0.321 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.542 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 84 | 87 | PF00400 | 0.321 |
TRG_NES_CRM1_1 | 17 | 30 | PF08389 | 0.539 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.380 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.336 |
TRG_Pf-PMV_PEXEL_1 | 87 | 92 | PF00026 | 0.321 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE86 | Leptomonas seymouri | 79% | 100% |
A0A3Q8IJ73 | Leishmania donovani | 89% | 100% |
A4ICI2 | Leishmania infantum | 89% | 100% |
O17731 | Caenorhabditis elegans | 31% | 99% |
P21673 | Homo sapiens | 37% | 92% |
P48026 | Mus musculus | 36% | 92% |
P49431 | Mus saxicola | 36% | 92% |
P79081 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 94% |
Q01612 | Mesocricetus auratus | 36% | 92% |
Q28999 | Sus scrofa | 37% | 92% |
Q3T0Q0 | Bos taurus | 37% | 92% |
Q53HX3 | Leishmania major | 88% | 100% |
Q6P8J2 | Mus musculus | 35% | 93% |
Q7PCJ8 | Bos taurus | 38% | 93% |
Q7PCJ9 | Sus scrofa | 36% | 93% |
Q8AXL1 | Gallus gallus | 37% | 92% |
Q96F10 | Homo sapiens | 36% | 93% |
Q9JHW6 | Cricetulus griseus | 36% | 92% |
Q9ZV05 | Arabidopsis thaliana | 25% | 69% |
Q9ZV06 | Arabidopsis thaliana | 26% | 67% |